article thumbnail

STAT+: Health AI investments are off to a roaring start in 2025

STAT

Over the last week, companies developing artificial intelligence products for health care have announced a series of impressive fundraises that set the tone for what could be a banner year for AI investment. Timed to the J.P.

Hospitals 318
article thumbnail

Opinion: The DEA’s 2025 quotas for opioids will leave seriously ill patients in pain

STAT

A woman sat in our emergency department in agonizing pain, feeling shaky, nauseous, and weak — drug withdrawal was setting in. But she wasn’t a “junkie” or even a recreational drug user. She was in her mid-60s with advanced cancer in her ovaries that had spread to her abdomen, causing unbearable pain.

364
364
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

European Pharmaceutical Review Issue 2 2025

European Pharmaceutical Review

Included in this issue of European Pharmaceutical Review : FOREWORD Setting rationale specifications for early-phase non-mutagenic impurities David Elder David P Elder Consultancy SUPPLY CHAIN Tariff risks and opportunities for pharma manufacturers Clifford Rossi, PhD, University of Maryland IN-DEPTH FOCUS: BIOPROCESS/BIOPRODUCTION Unlocking Europe’s (..)

52
article thumbnail

2025/26 CPAF screening questionnaire now open for completion

The Pharmacist

Pharmacy owners in England have been asked to complete a mandatory self-assessment questionnaire as part of the 2025/26 Community Pharmacy Assurance Framework (CPAF) process. The CPAF screening questionnaire opened on 1 July and is available to complete in the Manage Your Service (MYS) portal until 11:59pm on Thursday 31 July 2025.

article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

businesses in 2025. 📆 March 4, 2025 at 11:00 am PT, 2:00 pm ET, 7:00 pm GMT Key Takeaways: Insights into the latest payroll compliance trends affecting U.S. Strategies for managing multi-state compliance requirements with confidence. How automation and technology streamline payroll and mitigate compliance risks.

article thumbnail

Social Media Strategies in Pharma for the Second Half of 2025

Pharma Marketing Network

In 2025, the landscape of healthcare marketing is evolving faster than ever—and nowhere is this more evident than on social media. In 2025, pharma brands are shifting toward engagement-first models that prioritize dialogue over monologue. Moreover, 2025 has seen a surge in partnerships with health influencers and patient advocates.

article thumbnail

Health Canada approves Biocon Biologics’ YESAFILI, first EYLEA biosimilar, for launch in July 2025

Express Pharma

mL, and was granted on 26 June 2025. The company has scheduled the product’s Canadian launch for 4 July 2025. The post Health Canada approves Biocon Biologics’ YESAFILI, first EYLEA biosimilar, for launch in July 2025 appeared first on Express Pharma. The approval covers vial and prefilled syringe presentations, 2 mg/0.05